Fondaparinux sodium

Drug ingredient

CAS 114870-03-0

This chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.

Molecular structure of 114870-03-0 — 10 Na⁺

US productionNot reported

Import value, 2024$3.5B

Top sourceIreland 57%

This chemical is not on EPA’s Toxic Substances Control Act inventory, the list behind EPA’s production survey.

Why supply is unknown

Production is reported production, not a complete census of factories. Import value and source-country shares describe a shared customs category, not a separate chemical measurement.

Where It Comes From

Customs basis: HS 293299 · basket

These shares come from HS customs code 293299, which covers 229 tracked chemicals in total. They estimate the category's origin mix, not this chemical specifically.

Source Countries

Country of origin for US imports, from Census customs data (2024).

IE 57%IrelandNL 24%NetherlandsCH 8%SwitzerlandCN 5%ChinaIT 2%Italy

United Kingdom
Japan
Germany
Spain
Israel
Canada
Brazil
Vietnam
Ukraine
New Zealand
Belgium
Mexico
Singapore
Taiwan
South Korea
Sweden
South Africa
Egypt
Indonesia
Lithuania
Finland
Hungary
Czech Republic
Hong Kong
Malaysia
Slovakia
Australia
Russia
Jordan
Latvia
Argentina
Slovenia
Malta
Poland
Denmark
Austria

10 FDA-registered drug labelers

Aurobindo Pharma Limited

BrightGene Bio-Medical Technology Co., Ltd.

Dr. Reddy's Laboratories Limited

Eugia US LLC

Italfarmaco S.p.A

Jiangsu Hengrui Pharmaceuticals Co., Ltd.

Mylan Institutional LLC

Sandoz Inc.

ScinoPharm Taiwan Ltd.

Zydus Pharmaceuticals (USA) Inc.

Why It Matters

Sectors

Health

Downstream Uses

Appears in 2 drug and cosmetic product listings (FDA).

•fondaparinux sodium
•Arixtra

FDA Shortage Status

Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."

No Shortage

Shortage History

Rows group FDA shortage filings by drug product. Each manufacturer makes its own FDA shortage filing, so one product can carry several reports at once: Available, Limited Availability, Unavailable or to be discontinued.

to be discontinued
Fondaparinux Sodium Injection
Shortage listed since September 29, 2025

See all current drug shortages

Chemical Identity

CAS114870-03-0

PubChem CID636380

DTXSIDDTXSID501027612

FormulaC31H43N3Na10O49S8

Mol. Weight1728.1 g/mol

SMILESCOC1C(C(C(C(O1)COS(=O)(=O)[O-])OC2C(C(C(C(O2)C(=O)[O-])OC3C(C(C(C(O3)COS(=O)(=O)[O-])OC4C(C(C(C(O4)C(=O)[O-])OC5C(C(C(C(O5)COS(=O)(=O)[O-])O)O)NS(=O)(=O)[O-])O)O)OS(=O)(=O)[O-])NS(=O)(=O)[O-])O)OS(=O)(=O)[O-])O)NS(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]

Data Sources

PubChem · compound 636380Retrieved 2026-04-07
FDA National Drug Code directoryRetrieved 2026-04-25
FDA Drug ShortagesRetrieved 2026-10-04
US Census international tradeReporting year: 2024 · Retrieved 2026-10-04

← Back to Dashboard ← Back to Health

Brief citations

Fondaparinux sodium (CAS 114870-03-0) https://chemicalindependence.com/chemical/114870-03-0/ PubChem: 636380. Retrieved 2026-04-07. https://pubchem.ncbi.nlm.nih.gov/compound/636380 FDA National Drug Code directory: CAS 114870-03-0. Retrieved 2026-04-25. https://open.fda.gov/data/ndc/ FDA Drug Shortages: CAS 114870-03-0. Retrieved 2026-10-04. https://www.accessdata.fda.gov/scripts/drugshortages/ US Census international trade: HS 293299 for CAS 114870-03-0. Reporting year: 2024. https://usatrade.census.gov/